Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Moore

Showing results (1341-1350 of 1,421) with videos related to

Pageof 143
Sort By:
Cell|November 24, 2022
Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeysCyril Le Nouën, Christine E Nelson, Xueqiao Liu, et al.
NPJ Precision Oncology|April 25, 2025
The dynamic immune behavior of primary and metastatic ovarian carcinomaElaine Stur, Fuduan Peng, Pang-Ning Teng, et al.
JAMA Network Open|May 15, 2025
Long-Term Survival in Patients With Low-Risk Cervical Cancer After Simple, Modified, or Radical HysterectomyChristopher M Tarney, Chunqiao Tian, Leslie M Randall, et al.
Cognitive Research: Principles and Implications|February 28, 2023
The effect of pre-event instructions on eyewitness identificationMario J Baldassari, Kara N Moore, Ira E Hyman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2024
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal CancerMichael J Fusco, Sandra J Casak, Sirisha L Mushti, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Sex-Specific Skeletal Muscle Gene Expression Responses to Exercise Reveal Novel Direct Mediators of Insulin Sensitivity ChangeS Ma, M C Morris, M J Hubal, et al.
Gynecologic Oncology|June 8, 2026
Psychometric evaluation of the NFOSI-18 disease related symptoms - Physical, NFOSI-18 Total, and FACT GP5 in the recurrent ovarian cancer phase III study GY004Xiaodan Tang, Helen Huang, John D Peipert, et al.
Cell|May 20, 2025
Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic painRan Guo, Ouyang Chen, Yang Zhou, et al.
PNAS Nexus|July 25, 2022
An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaquesYongjun Sui, Jianping Li, Hanne Andersen, et al.
Gynecologic Oncology|August 25, 2023
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancerSandro Pignata, Michael Bookman, Jalid Sehouli, et al.
Pageof 143

Showing results (1341-1350 of 1,421) with videos related to

Sort By:
Pageof 143
Cell|November 24, 2022
Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeysCyril Le Nouën, Christine E Nelson, Xueqiao Liu, et al.
NPJ Precision Oncology|April 25, 2025
The dynamic immune behavior of primary and metastatic ovarian carcinomaElaine Stur, Fuduan Peng, Pang-Ning Teng, et al.
JAMA Network Open|May 15, 2025
Long-Term Survival in Patients With Low-Risk Cervical Cancer After Simple, Modified, or Radical HysterectomyChristopher M Tarney, Chunqiao Tian, Leslie M Randall, et al.
Cognitive Research: Principles and Implications|February 28, 2023
The effect of pre-event instructions on eyewitness identificationMario J Baldassari, Kara N Moore, Ira E Hyman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2024
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal CancerMichael J Fusco, Sandra J Casak, Sirisha L Mushti, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Sex-Specific Skeletal Muscle Gene Expression Responses to Exercise Reveal Novel Direct Mediators of Insulin Sensitivity ChangeS Ma, M C Morris, M J Hubal, et al.
Gynecologic Oncology|June 8, 2026
Psychometric evaluation of the NFOSI-18 disease related symptoms - Physical, NFOSI-18 Total, and FACT GP5 in the recurrent ovarian cancer phase III study GY004Xiaodan Tang, Helen Huang, John D Peipert, et al.
Cell|May 20, 2025
Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic painRan Guo, Ouyang Chen, Yang Zhou, et al.
PNAS Nexus|July 25, 2022
An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaquesYongjun Sui, Jianping Li, Hanne Andersen, et al.
Gynecologic Oncology|August 25, 2023
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancerSandro Pignata, Michael Bookman, Jalid Sehouli, et al.
Pageof 143